Cambrium logo — Engineering molecules to create performance that couldn't ex...

Cambrium

Engineering molecules to create performance that couldn't exist before.

Founded 2020 Germany Berlin, Germany 27 employees Seed Total: $8.00M Biotechnology, Manufacturing +3

General Information

Company Name Cambrium
Founded Year 2020
Location Germany Berlin, Germany
Founders / Decision Makers
Team member
Employees 27
Industries Biotechnology, Manufacturing, Robotics +2
Funding Stage Seed
Business Model B2B, Platform
Revenue Model Project Based, Product Sales, Licensing
Social

BounceWatch is an independent company data service, not affiliated with Cambrium. To contact Cambrium, visit cambrium.bio.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Cambrium compare?

A PDF of Cambrium and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Cambrium soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Event Participation Sep 24, 2026

Cambrium will participate as a speaker at an online Webinar on October 7, 2026, discussing biotechnology in scalp and hair care.

Product Launch Sep 24, 2026

Cambrium has launched EvoSance™, a new dual-action peptide system active for scalp care, supporting hair growth and resilience.

About Cambrium

Cambrium, founded in 2020, is at the forefront of revolutionizing material science. With the slogan, "Engineering molecules to create performance that couldn't exist before," the company is making strides in creating novel material building blocks using its proprietary Molecular Intelligence. Their innovation aims to close the gap left by stagnant decades in material sciences, unlocking previously inaccessible functionalities.

Operating from its headquarters in Germany and active in industries like Biotechnology, Manufacturing, Robotics, Clean Energy, and Machine Learning, Cambrium is pioneering a promising future in material innovation. The company recently secured Seed Round investment on 20 June 2024, supported by renowned investors such as Valor Equity Partners, DG Daiwa Ventures, and HOF Capital, among others.

With a strong investment backing and commitment to progress, Cambrium is poised to lead the next generation of breakthroughs in material science.

Business keywords: Molecular Engineering, Material Science, Synthetic Biology, Protein Building Blocks, Lab Automation, Novel Materials, High-Performance Materials, Biomanufacturing, Sustainable Manufacturing, Biomaterials Innovation, Environmental Impact, Economic Alignment, Advanced Materials

Services & Products

Developing high-performance materials
Designing enzymes, polymers, and peptides
Providing materials that outperform existing solutions

Target Customers

Apparel and Footwear Companies Automotive Industry Construction Sector Cosmetics Manufacturers Textiles Industry Home Care Products

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round Undisclosed 10
Valor Equity Partners, DG Daiwa Ventures +8
20 Jun 2024
Seed Round €8.00M 4
Valor Equity Partners, HOF Capital +2
31 Oct 2023
Seed Round Undisclosed 1
Merantix
18 Aug 2020

Cambrium Alternatives & Competitors

View All Alternatives
Cambrium vs

More than materials. 私たちは、持続可能なウェルビーイングに貢献するソリューションを提供しています。

95 employees
Biotechnology, Fashion
Cambrium vs

Biofiber manufacturers revolutionizing tissue engineering and advanced material applications

Grant
16 employees
Biotechnology, Manufacturing
Cambrium vs
ZymoChem
ZymoChem United States

Accelerating the Real-Zero Economy.

Seed
48 employees
Biotechnology, Energy

FAQ About Cambrium

Engineering molecules to create performance that couldn't exist before.
Cambrium was founded in 2020.
Cambrium is headquartered in Berlin, Germany.
Cambrium operates in Biotechnology, Manufacturing, Robotics, Clean Energy and Machine Learning. Its work centres on Molecular Engineering, Material Science, Synthetic Biology and Protein Building Blocks. Its customers include Apparel and Footwear Companies, Automotive Industry and Construction Sector.
Cambrium has a B2B and Platform business model. Its revenue comes from Project Based, Product Sales and Licensing.
Cambrium has approximately 27 employees.
Cambrium has completed 3 funding rounds, raising a total of $8.00M. The latest funding stage is Seed.
Cambrium offers: Developing high-performance materials, Designing enzymes, polymers, and peptides, Providing materials that outperform existing solutions.
Top alternatives and competitors to Cambrium include Spiber株式会社, 3DBioFibR Inc., ZymoChem, Markforged, Opentrons Labworks Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cambrium and Spiber株式会社 are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Cambrium, https://bouncewatch.com/company/cambrium, updated 25 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes